ArticleInfectious disease reports2026

Virologic, Lipid, Renal and Hepatic Laboratory Outcomes After Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in Treatment-Experienced People with HIV: Real-World Evidence from the SHINe-SHIC Cohort.

Manuela Ceccarelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.